Wed, September 4, 2024
Tue, September 3, 2024
Fri, August 30, 2024
Thu, August 29, 2024

Ashwani Verma Maintained (TEVA) at Strong Buy with Increased Target to $26 on, Sep 3rd, 2024


//stocks-investing.news-articles.net/content/202 .. with-increased-target-to-26-on-sep-3rd-2024.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Ashwani Verma of UBS, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Strong Buy with Increased Target from $24 to $26 on, Sep 3rd, 2024.

Ashwani has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 0 agree with Ashwani's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Ashwani


  • Balaji Prasad of "Barclays" Maintained at Buy with Increased Target to $22 on, Thursday, August 1st, 2024
  • Glen Santangelo of "Jefferies" Maintained at Strong Buy with Increased Target to $23 on, Thursday, June 27th, 2024
  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Increased Target to $21 on, Thursday, May 30th, 2024
  • David Amsellem of "Piper Sandler" Reiterated at Buy with Increased Target to $20 on, Monday, May 13th, 2024

Publication Contributing Sources